C. Tarby

发表

Assessing compound binding to the Eg5 motor domain using a thermal shift assay.

M. Doyle, V. Goldfarb, W. Metzler, 2009, Analytical biochemistry.

Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitors.

J. Fargnoli, J. Tokarski, G. Trainor, 2010, Bioorganic & medicinal chemistry letters.

Mild and general methods for the palladium-catalyzed cyanation of aryl and heteroaryl chlorides.

R. Cherney, Maxime C Soumeillant, C. Tarby, 2007, Organic letters.

Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors.

C. Tarby, 2004, Current topics in medicinal chemistry.

Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series.

Masaki Sudo, K. Kataoka, M. Ramirez-Weinhouse, 2008, Bioorganic & medicinal chemistry letters.

Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives.

Masaki Sudo, K. Kataoka, Hiroko Tanaka, 2004, Bioorganic & medicinal chemistry letters.

Synthesis, Chemical Properties, and Preliminary Evaluation of Substituted CBI Analogs of CC-1065 and the Duocarmycins Incorporating the 7-Cyano-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one Alkylation Subunit: Hammett Quantitation of the Magnitude of Electronic Effects on Functional Reactivity

D. Boger, C. Boyce, H. Cai, 1996 .

Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.

John Saunders, Doug Barnum, Minoru Imai, 2004, Bioorganic & medicinal chemistry letters.

Imidazotriazinecarbonitriles utiles comme inhibiteurs de kinase

Walter L Johnson, C. Tarby, Brian E. Fink, 2013 .

Chemical and Structural Comparison of N-BOC-CBQ and N-BOC-CBI: Identification and Structural Origin of an Unappreciated but Productive Stability of the CC-1065 and Duocarmycin SA Alkylation Subunits

D. Boger, P. Mésini, C. Tarby, 1994 .

Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.

D. Boger, W. Yun, C. Tarby, 1994, Bioorganic & medicinal chemistry.

A Hammett correlation for CC-1065 and duocarmycin analogs: magnitude of substituent electronic effects on functional reactivity.

D. Boger, J. A. Mckie, C. Tarby, 1996 .

Generalized Dipeptidomimetic Template: Solution Phase Parallel Synthesis of Combinatorial Libraries

D. Boger, L. Caporale, C. Tarby, 1996 .

Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series.

Wayne Vaccaro, Steven Sheriff, Neil Burford, 2006, Bioorganic & medicinal chemistry letters.

A solution-phase strategy for the synthesis of chemical libraries containing small organic molecules: a universal and dipeptide mimetic template.

D. Boger, L. Caporale, Daniel D. Comer, 1996, Bioorganic & medicinal chemistry.

PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032.

A. Fischman, R. Rubin, S. Galbraith, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modulation of cofilin phosphorylation by inhibition of the Lim family kinases.

J. Tokarski, G. Trainor, M. Poss, 2012, Bioorganic & medicinal chemistry letters.

Opportunities for novel therapeutic agents acting at chemokine receptors.

J. Saunders, C. Tarby, Saunders, 1999, Drug discovery today.